The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Role of Advanced Glycation End Products and Their Receptors in Development of Diabetic Neuropathy
Abstract
A bstract: Diabetic neuropathy is a life‐threatening complication involving both peripheral and autonomic nerves. The hyperglycemia‐induced polyol pathway as well as enhanced oxidative stress are among the factors implicated in the pathogenesis of diabetic neuropathy. Their effects are possibly exerted by direct nerve tissue damage or mediated by endothelial injury or vascular dysfunction. Formation of advanced glycation end product (AGE) is another important candidate for the cause of peripheral neuropathy. Indeed, the levels of AGEs were increased in the serum and also in the peripheral nerves obtained from diabetic patients. Structural and functional proteins of those nerves are also glycated, resulting in impaired nerve function and characteristic pathologic alterations. In addition, interaction between AGEs and their receptors induce biological effects on the target tissues for diabetic complications. In the peripheral nerve, the receptor for AGE (RAGE) is expressed in endothelial and Schwann cells. It is thus anticipated that interactions between AGEs and RAGE facilitate endoneural vascular dysfunction, leading to microangiopathy in the peripheral nerve. The roles of these mechanisms, in particular on the molecular mechanisms of AGE‐RAGE interactions in the development of diabetic neuropathy are largely still speculative and yet to be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Schmidt, A. M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Hegarty, H., Hurley, W., & Clauss, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42137-0 · Cited by 833
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Accelerated age-related browning of human collagen in diabetes mellitus.
Monnier, V. M., Kohn, R. R., & Cerami, A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.2.583 · Cited by 671
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Schmidt, A. M., Hasu, M., Popov, D., Zhang, J. H., Chen, J., Yan, S. D., Brett, J., Cao, R., Kuwabara, K., & Costache, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8807 · Cited by 326
Experimental diabetic neuropathy: an update
Sima, A. A. F., & Sugimoto, K. (1999) · Diabetologia · doi:10.1007/s001250051227 · Cited by 253
Greene, D. A., & Lattimer, S. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111030 · Cited by 244
Kihara, M., Schmelzer, J. D., Poduslo, J. F., Curran, G. L., Nickander, K. K., & Low, P. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.14.6107 · Cited by 207
Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus.
Vlassara, H., Brownlee, M., & Cerami, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5190 · Cited by 200
Neurotoxicity of Advanced Glycation End-Products for Cultured Cortical Neurons
Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y., & Makita, Z. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1094 · Cited by 198
Yagihashi, S., Kamijo, M., Baba, M., Yagihashi, N., & Nagai, K. (1992) · Diabetes · doi:10.2337/diab.41.1.47 · Cited by 192
Self-citationSugimoto, K., Nishizawa, Y., Horiuchi, S., & Yagihashi, S. (1997) · Diabetologia · doi:10.1007/s001250050839 · Cited by 159
Self-citationKarachalias, N., Babaei‐Jadidi, R., Ahmed, N., & Thornalley, P. J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311423 · Cited by 150
Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus.
Williams, S. K., Howarth, N. L., Devenny, J. J., & Bitensky, M. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6546 · Cited by 128
Stracke, H. H. G., Hammes, H., Werkmann, D., Mavrakis, K., Bitsch, I., Netzel, M. E., Geyer, J., Köpcke, W., Sauerland, C., Bretzel, R. G., et al. (2001) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2001-17399 · Cited by 107
Nitric oxide synthase activity and expression in retinal capillary endothelial cells and pericytes
Chakravarthy, U., Stitt, A. W., McNally, J., BAILIE, J. R., Hoey, E. M., & Duprex, W. P. (1995) · Current Eye Research · doi:10.3109/02713689509033528 · Cited by 106
Sekido, H., Suzuki, T., Jomori, T., Takeuchi, M., Yabe‐Nishimura, C., & Yagihashi, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.159 · Cited by 105
Self-citationEffects of OPB‐9195, anti‐glycation agent, on experimental diabetic neuropathy
Wada, R., Nishizawa, Y., Yagihashi, N., Takeuchi, M., Ishikawa, Y., YASUMURA, K., Nakano, M., & Yagihashi, S. (2001) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2001.00826.x · Cited by 93
Self-citationHamada, Y., Nakamura, J., Naruse, K., Komori, T., Kato, K., Kasuya, Y., Nagai, R., Horiuchi, S., & Hotta, N. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1539 · Cited by 93
Amore, A., Cirina, P., Mitola, S. M. F., Peruzzi, L., Gianoglio, B., Rabbone, I., Sacchetti, C., Cerutti, F., Grillo, C., & Coppo, R. (1997) · Kidney International · doi:10.1038/ki.1997.4 · Cited by 82
Tarsio, J. F., Wigness, B. D., Rhode, T. D., Rupp, W. M., Buchwald, H., & Furcht, L. T. (1985) · Diabetes · doi:10.2337/diab.34.5.477 · Cited by 69
Suárez, G., Rajaram, R., Bhuyan, K. C., Oronsky, A. L., & Goidl, J. A. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113641 · Cited by 63
Sugimoto, K., & Yagihashi, S. (1997) · Microvascular Research · doi:10.1006/mvre.1996.2002 · Cited by 58
Self-citationNA+/K+ATPase Impairment and Experimental Glycation: The Role of Glucose Autoxidation
Santini, S. A., Cotroneo, P., Marra, G., et al. (1996) · Free Radical Research · doi:10.3109/10715769609088036 · Cited by 22
Wada, R., Sugo, M., Nakano, M., & Yagihashi, S. (1999) · Diabetologia · doi:10.1007/s001250051223 · Cited by 19
Self-citation
Cited by
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives
Khalid, M., Petroianu, G., & Adem, A. (2022) · Biomolecules · doi:10.3390/biom12040542 · Cited by 879
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Mechanism of diabetic neuropathy: Where are we now and where to go?
Yagihashi, S., Mizukami, H., & Sugimoto, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00070.x · Cited by 488
Self-citation
Metadata
- Authors
- WADA, R., & YAGIHASHI, S.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 1043
- Issue
- 1
- Pages
- 598-604
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W1993428219
- Cited by
- 263
- References
- 28
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.